Article
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.
Cancer control : journal of the Moffitt Cancer Center - 1 Jan 2000
Cifuentes Claudia, Lombana Milton, Vargas Henry, Laguado Paola, Ruiz-Patiño Alejandro, Rojas Leonardo, Navarro Uriel, Vargas Carlos, Ricaurte Luisa, Arrieta Oscar, Zatarain-Barron Lucia, Zapata Leandro, González Guido, Ortiz Carlos, Bernal Laura, Restrepo Juan G, Viola Lucia, Grosso Fabio, Zapata Ricardo, Mantilla William, Carranza Hernán, Bustillo Iván, Llinas Néstor, Duarte Ricardo, Rodríguez July, Archila Pilar, Ávila Jenny, Bermúdez Maritza, Gámez Tatiana, Sotelo Carolina, Otero Jorge, Forero Elkin, Lema Mauricio, Limpias Catalina, Ordóñez-Reyes Camila, Mejía Sergio, Rolfo Christian, Rosell Rafael, Cardona Andrés F
Abstract excerpt
PURPOSE: Identifying actionable oncogenic mutations have changed the therapeutic landscape in different types of tumors. This study investigated the utility of comprehensive genomic profiling (CGP), a hybrid capture-based next-generation sequencing (NGS) assay, in clinical practice in a developing country. METHODS: In this retrospective cohort study, CGP was performed on clinical samples from patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.